Commitment to Advancing Health for All
Millions of Americans are living with unmet health needs. At Bayer, our focus is to discover and develop medicines that provide the opportunity to live a healthier life.
That’s why we’re continually expanding our pipeline portfolio in oncology and cardiovascular care, developing new approaches using cell and gene therapy, and delivering more options to help women make informed decisions about their health. Our portfolio also includes a long history of development in hematology and radiology.
We are bringing forth new treatments and making investments in many disease areas. Yet, our work doesn’t stop in the lab because innovation alone isn’t enough. Bayer is committed to addressing issues that create barriers to access optimal care. We know that every positive health outcome begins with a commitment to focus on the individual.
Each day, we are joining scientific and human approaches to create a complete focus on improving health for all Americans.
We’re committed to meeting the needs of patients in our therapeutic areas of focus, which include cardiovascular disease, pulmonary hypertension, hematology, oncology and women’s healthcare.
While we bring forth new treatments and make investments in many disease areas that affect Americans, we know that innovation is just one part of the story. We’re also working outside our labs, addressing the barriers to care that exist in this country — so no matter what, any patient can access the care they need.
Oncology
Bayer Oncology provides targeted precision therapies across a wide range of adult and pediatric tumor types, including prostate, colorectal, follicular lymphoma, kidney, liver, thyroid, and rare NTRK fusion cancers. Through strong clinical research and novel therapeutic approaches, we are dedicated to closing treatment gaps and improving health outcomes for patients.
Cardiovascular and Renal
As a global leader in cardiovascular and kidney health, Bayer develops vital therapies and digital tools designed to improve long-term patient outcomes. By collaborating with partners across all stages of clinical development, we are advancing new treatment approaches that focus on earlier diagnosis, better disease management, and more equitable access to care.
Pulmonary Hypertension
Bayer pioneered soluble guanylate cyclase (sGC) stimulation, a first-in-class mechanism that widens pulmonary blood vessels to lower lung blood pressure and relieve stress on the heart. By overcoming the limitations of previous therapies, this innovative approach provides the first approved drug treatments for both pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).
Women's Health
Building on a 60-year legacy of leadership—from pioneering oral contraceptives to leading the U.S. IUD market—Bayer develops innovative solutions that support women through every stage of life, including menopause management. We are also committed to addressing unmet gynecological needs and expanding access to trusted information and effective care in underserved communities.
Hemophilia
Building on a long-standing commitment to the community, Bayer provides proven therapies for hemophilia A while actively investing in next-generation research, including gene therapy approaches. By balancing current patient support with advanced clinical development, we aim to elevate the standard of care for people living with hemophilia worldwide.
Radiology
With over a century of commitment to radiology, Bayer supports imaging departments with a comprehensive portfolio of contrast agents, precision injection systems, and connected software for CT, MR, PET, and cardiovascular diagnostics. By partnering with equipment manufacturers and IT providers, we deliver integrated solutions designed to improve clinical workflows, enhance diagnostic precision, and guide effective patient care.
Frequently Asked Questions
What therapeutic areas does Bayer Pharmaceuticals focus on in the U.S.?
Bayer Pharmaceuticals in the United States focuses on oncology, cardiovascular and renal disease, pulmonary hypertension, women’s health, hemophilia and radiology.
How can patients get financial assistance?
Patients can explore Bayer patient assistance programs to view available support options, check eligibility and apply for assistance. Educational resources and support services are also available for eligible patients.
How does Bayer approach research and innovation?
Bayer uses biotechnology, precision medicine, digital insights, manufacturing scale and strategic partnerships to develop new therapies and diagnostic solutions. Our approach combines scientific rigor with a focus on patient needs and real-world impact.
Where can I find U.S. transparency disclosures and regulatory information?
U.S. transparency disclosures and regulatory information are available through Bayer’s U.S. transparency resources. These materials include public disclosures and links to required regulatory information.